XML 66 R54.htm IDEA: XBRL DOCUMENT v3.24.3
Intangible Assets (Details) - USD ($)
9 Months Ended
Feb. 02, 2025
Nov. 01, 2024
Aug. 01, 2024
May 03, 2024
Jan. 15, 2024
Sep. 30, 2024
Dec. 31, 2023
Intangible Assets [Line Items]              
Intangible assets license term         10 years    
Purchase price         $ 1,000,000    
Intangible asset payable         600,000    
Intangible assets           $ 2,884,549
Consideration paid           $ 400,000  
Common shares (in Shares)           950,000  
Common shares value           $ 492,850  
Fair value adjustment           $ 173,100  
Shares were fully vested (in Shares)   612,500 612,500 612,500   2,450,000  
Pharmaceutical [Member]              
Intangible Assets [Line Items]              
Fair value adjustment           $ 599,863  
Legal fees           12,320  
Acquiring license           $ 1,117,771  
License [Member]              
Intangible Assets [Line Items]              
Intangible assets license term           10 years  
Intangible asset payable         50,000    
Intangible assets           $ 861,452
License #2 (IPR&D asset) [Member]              
Intangible Assets [Line Items]              
Intangible assets           $ 2,023,097
Consideration Payable [Member]              
Intangible Assets [Line Items]              
Interest rate of percentage           11.75%  
Consideration Payable [Member] | License [Member]              
Intangible Assets [Line Items]              
Interest rate of percentage           11.75%  
March 15, 2025 [Member]              
Intangible Assets [Line Items]              
Intangible asset payable         $ 350,000    
Forecast [Member]              
Intangible Assets [Line Items]              
Shares were fully vested (in Shares) 612,500